← Back to Search

Community Resource Linkage for Opioid Use Disorder

N/A

Waitlist Available

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 years

Currently undergoing outpatient buprenorphine treatment through a provider or program at Massachusetts General Hospital

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, ~3 years from recruitment initiation

Awards & highlights

Study Summary

This trial is testing a new program to help people with opioid addiction by linking them to resources in their community.

Who is the study for?

This trial is for adults over 18 with an opioid use disorder diagnosis who are currently in outpatient treatment with buprenorphine, and started this treatment within the last year. It's not suitable for non-English speakers, individuals unable to consent due to neurodevelopmental disorders or neural trauma, or those experiencing active psychosis or suicidality.Check my eligibility

What is being tested?

The study tests a new intervention that helps people receiving medication for opioid addiction connect with recovery community centers. Participants will be randomly assigned to either this new approach or a control condition without such linkage, to compare outcomes.See study design

What are the potential side effects?

Since the interventions involve social support rather than medications beyond standard care (buprenorphine), typical drug side effects aren't expected. However, participants may experience emotional discomfort when discussing personal experiences during interviews.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am receiving outpatient buprenorphine treatment at Massachusetts General Hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, ~3 years from recruitment initiation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, ~3 years from recruitment initiation

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, ~3 years from recruitment initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Fidelity: Linkage manager adherence

Overall intervention acceptability

Overall intervention feasibility

+4 more

Secondary outcome measures

Change in recovery capital from baseline to Month 3

Feasibility of peer facilitator meet-ups

Intervention appropriateness

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Recovery Community Center Linkage (RCCL)Experimental Treatment1 Intervention

The RCCL arm will involve a brief (~20 minutes) meeting with a recovery coach (i.e. linkage manager), in which the recovery coach will inform the participant of recovery support services, including recovery community centers, and link them to a recovery community center, with the aid of a facilitated connection to a volunteer recovery community center member (i.e. peer facilitator). The linkage manager will also provide the participant with a list of recovery support service resources.

Group II: Control Condition (CC)Active Control1 Intervention

The CC arm will involve a time-matched meeting with a recovery coach (i.e. linkage manager), in which the recovery coach will broadly inform the participant of recovery support services, including recovery community centers, and provide them with a list of recovery support service resources.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,210 Total Patients Enrolled

Media Library

Recovery Community Center Linkage (RCCL) Clinical Trial Eligibility Overview. Trial Name: NCT05245513 — N/A

Opioid Use Disorder Research Study Groups: Control Condition (CC), Recovery Community Center Linkage (RCCL)

Opioid Use Disorder Clinical Trial 2023: Recovery Community Center Linkage (RCCL) Highlights & Side Effects. Trial Name: NCT05245513 — N/A

Recovery Community Center Linkage (RCCL) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05245513 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is sign-up currently open for this experiment?

"Clinicaltrials.gov reports that this specific medical trial is no longer actively recruiting candidates; the initial posting went out on January 1st 2023 and the data was last updated in August of 2022. Nonetheless, there are over 500 other trials currently seeking patients to participate."

Answered by AI

What is the ultimate goal of this clinical research?

"Over a 3-year period, this clinical trial aims to evaluate the efficacy of Recovery Community Centres in treating opioid use disorder. Secondary objectives include assessing participants' perceptions on the helpfulness of intervention and treatment through two single-item statements measured on a 10-point Likert scale; participant retention over Month 3 Follow Up; as well as the feasibility of training, implementation, maintenance and adoption via four additional single-item statements also assessed using a 10-point Likert scale."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial

Lauren Hoffman 2024. "Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05245513.